Neurodegenerative diseases such as Alzheimer's disease (AD) and Huntington's disease (HD) are characterized by the pathological deposition of amyloidogenic proteins which results in neurotoxicity and neurodegeneration. Aging is the greatest risk factor for these diseases, and as a result, interventions that delay aging also slow the progression of these age-associated diseases. As the precipitating events in AD and HD are thought to begin well before the onset of clinical symptoms, identifying processes early in life may be key to significantly alter the trajectory of these diseases. Our lab has recently discovered one such early-life event: naturally-occurring fluctuations in levels of reactive oxygen species (ROS) that are predictive of lifespan and stress resistance. These effects, identified in C. elegans, were found to be mediated by redox-dependent changes to the levels of trimethylated H3K4 (H3K4me3), an epigenetic mark associated with gene activation. These data demonstrate that transient changes in the levels of H3K4me3 during development can exert effects on organismal health and longevity that persist into adulthood. On this basis, we hypothesize that changes to H3K4me3 will also influence susceptibility to amyloid toxicity seen in AD and HD. In this study, we find that reduction of H3K4me3 levels by knockdown of
set-2 and
ash-2 (components of the H3K4me3 complex) in a C. elegans model strain of AD expressing amyloid-beta (Abeta) reduced Abeta-induced paralysis. A similar delay in paralysis was observed following transient exposure of Abeta-expressing animals to mild concentrations of the ROS-generator paraquat during development. Importantly, these protective effects of developmental ROS are lost in animals that lack
set-2. In addition to models of AD, C. elegans strains expressing amyloidogenic polyglutamine repeats (Q40) characteristic of HD were also protected from paralysis by
ash-2 or
set-2 knockdown, indicating that disruption of H3K4me3 levels can protect against proteotoxicity from multiple types of amyloidogenic proteins. Despite having a resistance to paralysis, polyglutamine-expressing animals with lower levels of H3K4me3 appear to have an increase in aggregation of the Q40 protein in both young and aged animals. We hypothesize that disruption of H3K4me3 may heighten the capacity of these animals to mount transcriptional responses to proteotoxic stress, and we are currently investigating the mechanisms that may confer this stress resistance.